Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Shares Outstanding (Weighted Average) (2023 - 2025)

Camp4 Therapeutics' Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $30.4 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 547.76% year-over-year to $30.4 million; the TTM value through Dec 2025 reached $30.4 million, up 547.76%, while the annual FY2025 figure was $30.4 million, 547.76% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $30.4 million at Camp4 Therapeutics, up from $22.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $30.4 million in Q4 2025 and bottomed at $394976.0 in Q4 2023.
  • The 3-year median for Shares Outstanding (Weighted Average) is $2.6 million (2024), against an average of $10.0 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) soared 39.21% in 2024 before it surged 4199.78% in 2025.
  • A 3-year view of Shares Outstanding (Weighted Average) shows it stood at $394976.0 in 2023, then skyrocketed by 1087.44% to $4.7 million in 2024, then surged by 547.76% to $30.4 million in 2025.
  • Per Business Quant, the three most recent readings for CAMP's Shares Outstanding (Weighted Average) are $30.4 million (Q4 2025), $22.6 million (Q3 2025), and $20.2 million (Q2 2025).